Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026 18:00:00
Swedencare Rg (Stockholm)
Poslední obchod Změna (%) Změna (SEK) Objem obchodů (SEK)
24,60 -0,61 -0,15 4 440 176
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 15.02.2026
Popis společnosti
Obecné informace
Název společnostiSwedencare AB (publ)
TickerSECARE
Kmenové akcie:Ordinary Shares
RICSECARE.ST
ISINSE0015988167
Poslední známé roční výsledky31.12.2025
Poslední známé čtvrtletní výsledky31.12.2025
Počet zaměstnanců k 30.09.2025 609
Akcie v oběhu k 30.09.2025 159 840 958
MěnaSEK
Kontaktní informace
UlicePer Albin Hanssons Vag 41
MěstoMALMO
PSČ214 32
ZeměSweden
Kontatní osoba 
Funkce kontaktní osoby 
Telefon 464 085 933

Business Summary: Swedencare AB (publ) is a Sweden-based company which is mainly involved in the veterinary supplies industry. The company scope of activity includes manufacturing, developing and sale of products in the field of animal health care and preventive dental care products made of seaweed selected cold North Atlantic waters off the Scandinavian coastline. The Company operates as a provider of various products for animal health, distributed to veterinarians, pet stores as well as pharmacies. The Company's product portfolio includes ProDen product family, which consists of ProDen PlaqueOff Teeth and Gums, ProDen PlaqueOff Dental Bites, among others. The products are available at veterinary clinics, pet retailers, pharmacies, health stores and dentist practices.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Swedencare AB (publ) revenues increased 7% to SEK2.01B. Net income applicable to common stockholders decreased 48% to SEK39.2M. Revenues reflect Europe segment increase of 30% to SEK419.8M, North America segment increase of 4% to SEK1.23B, Rest of Europe segment increase of 27% to SEK466.4M, North American segment increase of 2% to SEK1.38B.
Odvětvová klasifikace
TRBC2012Veterinary Drugs
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSPharmaceutical Preparation Manufacturing
NAICSVeterinary Services
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Veterinary Services
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Veterinary Services
SICPharmaceutical Preparations
SICVeterinary Services, Specialties



  • Poslední aktualizace: 15.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive OfficerHakan Lagerberg5728.04.2022
Chief Financial OfficerJenny Graflind4924.06.202001.01.2017
Chief Executive Officer - Fulfillment Advantage Ventures IncTim Ackerman-01.01.2021
Chief Executive Officer - Rx Vitamins Inc.Lynn Bowgren-01.01.2023
Chief Executive Officer - NaturVetGeoff Granger-01.01.2023
Chief Executive Officer - Pet MD Brands LLCEd Holden44
Chief Executive Officer - Nutravet UK LtdChris Jones-01.01.2021
Chief Executive Officer - Swedencare UK Ltd and Swedencare IrelandJohn Leonard60
Chief Executive Officer - Custom Vet Products LtdDavid Ryder-01.01.2022
Chief Executive Officer - Swedencare USA Inc. and Swedencare Tillverka IncMartin Shimko61